Tromethamine

Tromethamine

SCHEMBL1019735

NC(CO)(CO)CO.O=C(COCC(=O)Nc1ccc(Cl)cc1C(=O)O)Nc1cccc(-c2ccoc2)c1

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

DHFRGARTPTGFRPTGIRPTGS1PTGS2TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8envmurAthyA

The experimentally established mechanism targets of Tromethamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 8/20 0.68
CNR1 P21554 1/20 0.48
POLB P06746 2/20 0.43
G6PD P11413 1/20 0.43
GRIK1 P39086 1/20 0.41
MAPT P10636 4/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPK1 P28482 1/20 0.39
MPO P05164 1/20 0.39
GAA P10253 2/20 0.38
KDM4E B2RXH2 1/20 0.38
XBP1 P17861 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
KLK7 P49862 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1016107 0.93 SERPINE1 (0.77) SERPINE1CNR1POLBG6PDGRIK1
SCHEMBL29492572 0.93 SERPINE1 (0.77) SERPINE1CNR1POLBG6PDGRIK1
SCHEMBL22468222 0.92 SERPINE1 (0.75) SERPINE1CNR1POLBG6PDGRIK1
SCHEMBL1019736 0.89 SERPINE1 (0.56) SERPINE1CNR1POLBMAPTMEN1
SCHEMBL1012706 0.85 SERPINE1 (0.80) SERPINE1CNR1POLBG6PDGRIK1
SCHEMBL29448187 0.84 SERPINE1 (0.64) SERPINE1CNR1POLBG6PDMAPT
SCHEMBL1015662 0.84 SERPINE1 (0.64) SERPINE1CNR1POLBMAPTMEN1
SCHEMBL20814655 0.83 SERPINE1 (0.61) SERPINE1CNR1POLBG6PDGRIK1
SCHEMBL1014817 0.83 SERPINE1 (0.76) SERPINE1CNR1POLBG6PDGRIK1
SCHEMBL20814653 0.83 SERPINE1 (0.60) SERPINE1CNR1POLBG6PDGRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 SERPINE1 1/4885CNR1 3950/4885POLB 2992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.